GNRH2 and ovarian carcinoma: Recently, we showed that antagonistic analogues of GnRH-II induced apoptotic cell death in human endometrial and ovarian cancer cells in vitro, via dose-dependent loss of mitochondrial membrane potential and activation of caspase-3 [17].